DCGI Implements New Regulatory Code for Drug Inspectors to Improve Market Vigilance

Overview of the New DCGI Code

The Drugs Controller General of India (DCGI) has put forth a significant update in the form of a new code for drug inspectors across the country. This initiative aims to enhance market vigilance through a standardized approach to inspections and sampling.

Key Features of the New Code

• Uniform Sampling Methods: Drug inspectors are now required to adopt consistent sampling techniques, which will aid in identifying risks more effectively.
• Focus on Rural Areas: The code mandates the inclusion of rural regions in inspection plans to ensure comprehensive coverage.
• Centralized Reporting: Inspectors must maintain a monthly list of sub-standard drugs to ensure transparency and swift action against unsafe products.

Impact on Drug Regulation

This new guidance replaces over a decade-old framework, addressing the advancements in the regulatory system. It reflects a proactive approach towards monitoring the market for drugs, cosmetics, and medical devices, ultimately aiming to boost consumer safety.